Letko, Brosseau & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Letko, Brosseau & Associates's MDT Position: Q1 2018 in Review
Letko, Brosseau & Associates sold out of Medtronic (MDT) in Q1 2018, closing a stake of 365,075 shares — an estimated $29.5M sold.
Letko, Brosseau & Associates first reported a position in MDT in Q2 2013 and held it in 19 quarters. The position peaked at $55.7M in Q1 2015. 1,382 funds tracked by Wall St. Rank hold MDT as of Q1 2018.
- Letko, Brosseau & Associates reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
- Letko, Brosseau & Associates sold 365,075 Medtronic shares in Q1 2018, an estimated $29.5M.
- Letko, Brosseau & Associates first reported a position in Medtronic in Q2 2013 and held it in 19 quarters.
- Letko, Brosseau & Associates's Medtronic position peaked at $55.7M in Q1 2015.
- 1,382 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.
Based on Letko, Brosseau & Associates's 13F filing for Q1 2018, filed 8 May 2018.